ESG ratings & risk scores
ESG Solutions
Common questions
At a glance
Verified June 2026ESG & Sustainability Profile
Key Facts
- • 2030, alongside efforts to ensure affordable healthcare for underserved communities.
Novartis, a multinational company in pharmaceuticals, has made substantial commitments to ESG principles, particularly in healthcare accessibility and sustainability. The company has set ambitious goals to reduce its carbon emissions and achieve net-zero emissions by 2030, alongside efforts to ensure affordable healthcare for underserved communities. Novartis’ ESG rating highlights its contributions to innovative treatments and global health. However, the company faces criticism regarding drug pricing and its historical ties to controversies over opioid distribution in some markets. Novartis' ESG score reflects a strong focus on environmental and social responsibility, but it must address governance and pricing concerns to further enhance its credibility. The latest Novartis ESG report...
Showing preview (4 paragraphs of 4 total)
Key Insights
Key Insights
Covered by 2 ESG rating providers
Limited coverage
Net Zero target: 2040
14 years to achieve
Science Based Targets approved
Validated emissions reduction pathway
Sustainability Commitments & Climate Targets
Novartis AG ESG Rating Coverage - Sustainalytics & LSEG
Analyzed by both major ESG rating providers - verified
| Provider | Coverage | Details |
|---|---|---|
Morningstar Sustainalytics ESG Risk Ratings | Covered | |
LSEG (Refinitiv) ESG Scores & Data | Covered |
Coverage verified from 2 of 2 active providers.
ESG Rating Provider Coverage
MSCI ESG Ratings
Measures company exposure to industry-specific ESG risks and management of those risks relative to peers.
MSCI identifies the ESG risks most relevant to each industry, then scores companies on how well they manage those risks compared to peers. Ratings range from AAA (leader) to CCC (laggard) and are reviewed annually.
View on MSCIMorningstar Sustainalytics ESG Risk Ratings
Assesses the degree to which a company's economic value is at risk driven by ESG factors.
Sustainalytics measures unmanaged ESG risk — the gap between a company's total exposure to material ESG issues and how much of that exposure its management practices address. Lower scores indicate less unmanaged risk.
View on SustainalyticsLSEG (Refinitiv) ESG Scores
Evaluates company ESG performance based on publicly available, verifiable data across 630+ metrics.
LSEG scores companies across 630+ ESG data points drawn entirely from public disclosures — annual reports, sustainability filings, and regulatory submissions. Scores are weighted by industry materiality and benchmarked against sector peers.
View on LSEGCoverage status indicates whether publicly available ESG data from each provider has been identified for Novartis AG. For official ratings and scores, visit provider websites directly.
ESG Solutions for HealthCare
She+ Geeks Out
She+ Geeks Out helps organizations evolve with strategic consulting, coaching, and learning, centering people at the core.
Syndio
Syndio empowers enterprises with AI-powered compensation workflows, ensuring fair pay decisions and compliance with EUPTD standards.
Eskalera
Eskalera provides advanced tools for enhancing workplace diversity, equity, and inclusion, driving positive social impact.
Inclusion Score
Inclusion Score offers innovative tools to enhance diversity, equity, and inclusion in organizations worldwide.
Trusaic
Trusaic offers trusted pay equity and transparency solutions, helping businesses comply with DEI regulations globally.
Edge Certification
Edge Certification provides comprehensive social governance solutions to promote gender equality and sustainable practices globally.
Frequently Asked Questions
Find answers to common questions about Novartis AG's ESG practices, sustainability initiatives, and provider coverage.
Have more questions? Visit our Sustainability, Climate & ESG FAQs or contact our team.